{"id":344694,"date":"2025-08-24T13:48:43","date_gmt":"2025-08-24T13:48:43","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-novartis-ag\/"},"modified":"2025-08-24T13:48:43","modified_gmt":"2025-08-24T13:48:43","slug":"how-to-buy-novartis-ag","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Novartis AG (NVS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Novartis AG (NVS)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334027,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-344694","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Novartis AG (NVS) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Novartis AG (NVS)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Novartis AG (NVS) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Novartis AG (NVS)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Novartis AG (NVS) v\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o t\u1eadp \u0111o\u00e0n d\u01b0\u1ee3c ph\u1ea9m kh\u1ed5ng l\u1ed3 n\u00e0y. Kh\u00e1m ph\u00e1 gi\u00e1 c\u1ed5 phi\u1ebfu hi\u1ec7n t\u1ea1i, r\u1ee7i ro v\u00e0 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng cho giai \u0111o\u1ea1n 2025-2030.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Novartis AG (NVS) v\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o t\u1eadp \u0111o\u00e0n d\u01b0\u1ee3c ph\u1ea9m kh\u1ed5ng l\u1ed3 n\u00e0y. Kh\u00e1m ph\u00e1 gi\u00e1 c\u1ed5 phi\u1ebfu hi\u1ec7n t\u1ea1i, r\u1ee7i ro v\u00e0 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng cho giai \u0111o\u1ea1n 2025-2030."},"intro":"H\u00e3y t\u01b0\u1edfng t\u01b0\u1ee3ng b\u1ea1n s\u1edf h\u1eefu m\u1ed9t ph\u1ea7n c\u1ee7a m\u1ed9t trong nh\u1eefng c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m l\u1edbn nh\u1ea5t th\u1ebf gi\u1edbi, \u0111ang thay \u0111\u1ed5i y h\u1ecdc m\u1ed7i ng\u00e0y. Novartis AG \u0111\u1ea1i di\u1ec7n cho s\u1ef1 \u1ed5n \u0111\u1ecbnh, \u0111\u1ed5i m\u1edbi v\u00e0 \u1ea3nh h\u01b0\u1edfng to\u00e0n c\u1ea7u trong l\u0129nh v\u1ef1c ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe\u2014l\u00fd t\u01b0\u1edfng cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 t\u00ecm ki\u1ebfm c\u1ea3 t\u0103ng tr\u01b0\u1edfng v\u00e0 v\u1ecb th\u1ebf ph\u00f2ng th\u1ee7. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao c\u1ed5 phi\u1ebfu NVS x\u1ee9ng \u0111\u00e1ng \u0111\u01b0\u1ee3c b\u1ea1n quan t\u00e2m v\u00e0 c\u00e1ch b\u1ea1n c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh m\u1ed9t ph\u1ea7n c\u1ee7a cu\u1ed9c c\u00e1ch m\u1ea1ng y h\u1ecdc n\u00e0y.","intro_source":{"label":"Intro","type":"text","formatted_value":"H\u00e3y t\u01b0\u1edfng t\u01b0\u1ee3ng b\u1ea1n s\u1edf h\u1eefu m\u1ed9t ph\u1ea7n c\u1ee7a m\u1ed9t trong nh\u1eefng c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m l\u1edbn nh\u1ea5t th\u1ebf gi\u1edbi, \u0111ang thay \u0111\u1ed5i y h\u1ecdc m\u1ed7i ng\u00e0y. Novartis AG \u0111\u1ea1i di\u1ec7n cho s\u1ef1 \u1ed5n \u0111\u1ecbnh, \u0111\u1ed5i m\u1edbi v\u00e0 \u1ea3nh h\u01b0\u1edfng to\u00e0n c\u1ea7u trong l\u0129nh v\u1ef1c ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe\u2014l\u00fd t\u01b0\u1edfng cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 t\u00ecm ki\u1ebfm c\u1ea3 t\u0103ng tr\u01b0\u1edfng v\u00e0 v\u1ecb th\u1ebf ph\u00f2ng th\u1ee7. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao c\u1ed5 phi\u1ebfu NVS x\u1ee9ng \u0111\u00e1ng \u0111\u01b0\u1ee3c b\u1ea1n quan t\u00e2m v\u00e0 c\u00e1ch b\u1ea1n c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh m\u1ed9t ph\u1ea7n c\u1ee7a cu\u1ed9c c\u00e1ch m\u1ea1ng y h\u1ecdc n\u00e0y."},"body_html":"<h2>\ud83d\udcc8 Ph\u00e2n T\u00edch C\u1ed5 Phi\u1ebfu Novartis: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 V\u1ecb Th\u1ebf Th\u1ecb Tr\u01b0\u1eddng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 24 th\u00e1ng 8 n\u0103m 2025, Novartis AG (NVS) giao d\u1ecbch \u1edf m\u1ee9c <strong>126,98 USD<\/strong>\u2014m\u1ed9t v\u1ecb th\u1ebf m\u1ea1nh ph\u1ea3n \u00e1nh hi\u1ec7u su\u1ea5t v\u1eefng ch\u1eafc c\u1ee7a c\u00f4ng ty v\u00e0 s\u1ef1 tin t\u01b0\u1edfng c\u1ee7a th\u1ecb tr\u01b0\u1eddng. T\u1eadp \u0111o\u00e0n d\u01b0\u1ee3c ph\u1ea9m Th\u1ee5y S\u0129 n\u00e0y kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t c\u1ed5 phi\u1ebfu th\u00f4ng th\u01b0\u1eddng; n\u00f3 l\u00e0 n\u1ec1n t\u1ea3ng c\u1ee7a s\u1ef1 \u0111\u1ed5i m\u1edbi trong ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe to\u00e0n c\u1ea7u.<\/p> <p><strong>\u0110\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: Ng\u00e0y 4 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y quan tr\u1ecdng ti\u1ebfp theo. \u0110\u00f3 l\u00e0 khi Novartis c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3, v\u00e0 theo l\u1ecbch s\u1eed, nh\u1eefng th\u00f4ng b\u00e1o n\u00e0y t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3. B\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn g\u1ea7n nh\u1ea5t c\u1ee7a c\u00f4ng ty v\u00e0o ng\u00e0y 17 th\u00e1ng 7 n\u0103m 2025 cho th\u1ea5y k\u1ebft qu\u1ea3 \u1ea5n t\u01b0\u1ee3ng v\u1edbi t\u0103ng tr\u01b0\u1edfng doanh s\u1ed1 hai ch\u1eef s\u1ed1 v\u00e0 m\u1edf r\u1ed9ng bi\u00ean l\u1ee3i nhu\u1eadn c\u1ed1t l\u00f5i.<\/p> <h3>C\u00e1ch B\u00e1o C\u00e1o L\u1ee3i Nhu\u1eadn \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu NVS<\/h3> <table> <thead> <tr><th>Ng\u00e0y<\/th><th>S\u1ef1 ki\u1ec7n<\/th><th>T\u00e1c \u0111\u1ed9ng Gi\u00e1<\/th><th>Th\u1eddi gian<\/th><\/tr> <\/thead> <tbody> <tr><td>17 th\u00e1ng 7, 2025<\/td><td>L\u1ee3i Nhu\u1eadn Qu\u00fd 2 V\u01b0\u1ee3t K\u1ef3 V\u1ecdng<\/td><td>+3,2%<\/td><td>2 ng\u00e0y<\/td><\/tr> <tr><td>22 th\u00e1ng 4, 2025<\/td><td>K\u1ebft Qu\u1ea3 Qu\u00fd 1<\/td><td>+2,1%<\/td><td>1 tu\u1ea7n<\/td><\/tr> <tr><td>5 th\u00e1ng 2, 2025<\/td><td>B\u00e1o C\u00e1o H\u00e0ng N\u0103m<\/td><td>+4,8%<\/td><td>3 ng\u00e0y<\/td><\/tr> <tr><td>29 th\u00e1ng 10, 2024<\/td><td>L\u1ee3i Nhu\u1eadn Qu\u00fd 3<\/td><td>-1,5%<\/td><td>Gi\u1ea3m nh\u1eb9<\/td><\/tr> <tr><td>18 th\u00e1ng 7, 2024<\/td><td>K\u1ebft Qu\u1ea3 Qu\u00fd 2<\/td><td>+3,6%<\/td><td>T\u0103ng tr\u01b0\u1edfng b\u1ec1n v\u1eefng<\/td><\/tr> <tr><td>23 th\u00e1ng 4, 2024<\/td><td>Hi\u1ec7u Su\u1ea5t Qu\u00fd 1<\/td><td>+2,3%<\/td><td>T\u0103ng \u0111\u1ec1u<\/td><\/tr> <\/tbody> <\/table> <p>M\u1eabu h\u00ecnh cho th\u1ea5y Novartis th\u01b0\u1eddng tr\u1ea3i qua \u0111\u00e0 t\u0103ng t\u00edch c\u1ef1c sau c\u00e1c b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn m\u1ea1nh, v\u1edbi nh\u1eefng \u0111i\u1ec1u ch\u1ec9nh nh\u1ecf th\u1ec9nh tho\u1ea3ng t\u1ea1o c\u01a1 h\u1ed9i mua v\u00e0o.<\/p>  [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: Th\u00e1ng 1 - Th\u00e1ng 8 N\u0103m 2025<\/h2> <p>C\u1ed5 phi\u1ebfu Novartis \u0111\u00e3 th\u1ec3 hi\u1ec7n s\u1ef1 ki\u00ean c\u01b0\u1eddng v\u00e0 t\u0103ng tr\u01b0\u1edfng \u0111\u00e1ng k\u1ec3 trong s\u00e1u th\u00e1ng qua:<\/p> <ul> <li><strong>Th\u00e1ng 1 n\u0103m 2025<\/strong>: B\u1eaft \u0111\u1ea7u quanh m\u1ee9c 96,91 USD, t\u0103ng +7,61% khi nh\u00e0 \u0111\u1ea7u t\u01b0 nh\u1eadn ra l\u1ee3i \u00edch t\u1eeb t\u00e1i c\u1ea5u tr\u00fac c\u00f4ng ty<\/li> <li><strong>Th\u00e1ng 2 n\u0103m 2025<\/strong>: \u0110\u00e0 t\u0103ng ti\u1ebfp t\u1ee5c v\u1edbi +4,13%, \u0111\u1ea1t \u0111\u1ec9nh 113 USD nh\u1edd tin t\u1ee9c t\u00edch c\u1ef1c v\u1ec1 danh m\u1ee5c s\u1ea3n ph\u1ea9m<\/li> <li><strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: T\u0103ng \u1ed5n \u0111\u1ecbnh +2,23% khi th\u1ecb tr\u01b0\u1eddng ti\u1ebfp nh\u1eadn k\u1ef3 v\u1ecdng qu\u00fd 1<\/li> <li><strong>Th\u00e1ng 4 n\u0103m 2025<\/strong>: Giai \u0111o\u1ea1n bi\u1ebfn \u0111\u1ed9ng (+1,80%) v\u1edbi dao \u0111\u1ed9ng r\u1ed9ng t\u1eeb 97,72 \u0111\u1ebfn 114,70 USD<\/li> <li><strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: T\u0103ng tr\u01b0\u1edfng v\u1eefng ch\u1eafc +2,00% gi\u1eefa k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng t\u00edch c\u1ef1c<\/li> <li><strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: Ph\u1ee5c h\u1ed3i m\u1ea1nh +4,54% khi tin t\u1ee9c mua l\u1ea1i n\u00e2ng cao ni\u1ec1m tin<\/li> <li><strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: \u0110i\u1ec1u ch\u1ec9nh nh\u1eb9 -3,62% do ch\u1ed1t l\u1eddi sau \u0111\u1ee3t t\u0103ng m\u1ea1nh<\/li> <li><strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: Ph\u1ee5c h\u1ed3i l\u00ean m\u1ee9c hi\u1ec7n t\u1ea1i 126,98 USD, th\u1ec3 hi\u1ec7n s\u1ef1 tin t\u01b0\u1edfng c\u1ee7a nh\u00e0 \u0111\u1ea7u t\u01b0<\/li> <\/ul> <p><strong>T\u1ed5ng l\u1ee3i nhu\u1eadn 6 th\u00e1ng: Kho\u1ea3ng 28%<\/strong>\u2014v\u01b0\u1ee3t tr\u1ed9i so v\u1edbi nhi\u1ec1u \u0111\u1ed1i th\u1ee7 trong ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m v\u00e0 ch\u1ee9ng minh t\u1ea1i sao NVS v\u1eabn l\u00e0 l\u1ef1a ch\u1ecdn y\u00eau th\u00edch c\u1ee7a c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 t\u0103ng tr\u01b0\u1edfng.<\/p>  <h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p>D\u1ef1a tr\u00ean d\u1ef1 b\u00e1o c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch hi\u1ec7n t\u1ea1i v\u00e0 hi\u1ec7u su\u1ea5t c\u00f4ng ty, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec b\u1ea1n c\u00f3 th\u1ec3 mong \u0111\u1ee3i:<\/p> <ul> <li><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: 129-135 USD (qu\u00fd l\u1ec5 m\u1ea1nh v\u00e0 ph\u00e1t tri\u1ec3n danh m\u1ee5c s\u1ea3n ph\u1ea9m) \u2192 <strong>MUA<\/strong><\/li> <li><strong>M\u1ee5c ti\u00eau 2026<\/strong>: 140-150 USD (t\u00edch h\u1ee3p th\u00e0nh c\u00f4ng c\u00e1c th\u01b0\u01a1ng v\u1ee5 mua l\u1ea1i g\u1ea7n \u0111\u00e2y)<\/li> <li><strong>D\u1ef1 b\u00e1o 2028<\/strong>: 160-180 USD (th\u1ed1ng l\u0129nh trong li\u1ec7u ph\u00e1p gen v\u00e0 mi\u1ec5n d\u1ecbch h\u1ecdc)<\/li> <li><strong>T\u1ea7m nh\u00ecn 2030<\/strong>: Tr\u00ean 200 USD (m\u1edf r\u1ed9ng ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe to\u00e0n c\u1ea7u v\u00e0 xu h\u01b0\u1edbng d\u00e2n s\u1ed1 gi\u00e0 h\u00f3a)<\/li> <\/ul> <p>\u0110a s\u1ed1 c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u1eabn gi\u1eef quan \u0111i\u1ec3m t\u00edch c\u1ef1c m\u1eb7c d\u00f9 c\u00f3 nh\u1eefng lo ng\u1ea1i v\u1ec1 b\u1eb1ng s\u00e1ng ch\u1ebf trong ng\u1eafn h\u1ea1n. Chi\u1ebfn l\u01b0\u1ee3c t\u1eadp trung v\u00e0o thu\u1ed1c \u0111\u1ed5i m\u1edbi v\u00e0 c\u00e1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng th\u00e0nh c\u00f4ng g\u1ea7n \u0111\u00e2y gi\u00fap Novartis c\u00f3 v\u1ecb th\u1ebf t\u0103ng tr\u01b0\u1edfng b\u1ec1n v\u1eefng d\u00e0i h\u1ea1n.<\/p>  <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i Ro C\u1ea7n L\u01b0u \u00dd<\/h3> <ul> <li><strong>H\u1ebft h\u1ea1n b\u1eb1ng s\u00e1ng ch\u1ebf<\/strong>: Entresto, thu\u1ed1c mang l\u1ea1i 2,36 t\u1ef7 USD doanh thu qu\u00fd, s\u1eafp \u0111\u1ed1i m\u1eb7t v\u1edbi c\u1ea1nh tranh thu\u1ed1c generic (<a href=\"https:\/\/www.ainvest.com\/news\/novartis-growth-slow-patent-expirations-loom-2507\/\">B\u00e1o c\u00e1o AInvest<\/a>)<\/li> <li><strong>\u00c1p l\u1ef1c qu\u1ea3n l\u00fd<\/strong>: FDA t\u0103ng c\u01b0\u1eddng gi\u00e1m s\u00e1t v\u1edbi 907 th\u01b0 c\u1ea3nh b\u00e1o n\u0103m 2023 (+12% so v\u1edbi 2022)<\/li> <li><strong>C\u1ea3i c\u00e1ch gi\u00e1 thu\u1ed1c<\/strong>: C\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng 15-20% doanh thu t\u1eeb \u0111\u1ec1 xu\u1ea5t gi\u00e1 thu\u1ed1c c\u1ee7a ch\u00ednh ph\u1ee7 M\u1ef9<\/li> <li><strong>M\u1ee9c n\u1ee3<\/strong>: T\u1ef7 l\u1ec7 n\u1ee3 tr\u00ean v\u1ed1n ch\u1ee7 s\u1edf h\u1eefu 0,53 c\u1ea7n \u0111\u01b0\u1ee3c theo d\u00f5i ch\u1eb7t ch\u1ebd<\/li> <\/ul> <h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h3> <ul> <li><strong>Danh m\u1ee5c s\u1ea3n ph\u1ea9m m\u1ea1nh<\/strong>: K\u1ebft qu\u1ea3 giai \u0111o\u1ea1n 3 t\u00edch c\u1ef1c cho ianalumab trong b\u1ec7nh Sj\u00f6gren v\u00e0 ITP<\/li> <li><strong>Th\u01b0\u01a1ng v\u1ee5 chi\u1ebfn l\u01b0\u1ee3c<\/strong>: Ho\u00e0n t\u1ea5t th\u01b0\u01a1ng v\u1ee5 1,7 t\u1ef7 USD mua Regulus Therapeutics, t\u0103ng c\u01b0\u1eddng n\u0103ng l\u1ef1c microRNA<\/li> <li><strong>L\u00e3nh \u0111\u1ea1o th\u1ecb tr\u01b0\u1eddng<\/strong>: X\u1ebfp h\u1ea1ng #5 v\u1ec1 doanh s\u1ed1 d\u01b0\u1ee3c ph\u1ea9m to\u00e0n c\u1ea7u v\u1edbi \u0111\u1ea7u t\u01b0 R&D kh\u1ed5ng l\u1ed3<\/li> <li><strong>\u1ed4n \u0111\u1ecbnh c\u1ed5 t\u1ee9c<\/strong>: L\u1ee3i su\u1ea5t 3,53% cung c\u1ea5p thu nh\u1eadp trong bi\u1ebfn \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng<\/li> <\/ul>  <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: M\u1edf v\u1ecb th\u1ebf kh\u00f4ng qu\u00e1 5% danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n<\/li> <li><strong>Trung b\u00ecnh gi\u00e1<\/strong>: \u0110\u1ea7u t\u01b0 s\u1ed1 ti\u1ec1n c\u1ed1 \u0111\u1ecbnh \u0111\u1ec1u \u0111\u1eb7n thay v\u00ec c\u1ed1 g\u1eafng b\u1eaft th\u1eddi \u0111i\u1ec3m th\u1ecb tr\u01b0\u1eddng<\/li> <li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/strong>: Theo d\u00f5i b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn ng\u00e0y 4 th\u00e1ng 11 \u0111\u1ec3 t\u00ecm \u0111i\u1ec3m v\u00e0o ti\u1ec1m n\u0103ng<\/li> <li><strong>Suy ngh\u0129 d\u00e0i h\u1ea1n<\/strong>: C\u1ed5 phi\u1ebfu d\u01b0\u1ee3c ph\u1ea9m \u0111\u00f2i h\u1ecfi ki\u00ean nh\u1eabn\u2014kh\u00f4ng ph\u1ea3i c\u01a1 h\u1ed9i l\u01b0\u1edbt s\u00f3ng nhanh<\/li> <\/ol> <p>Ch\u00e2m bi\u1ebfm: \"Giao d\u1ecbch NVS gi\u1ed1ng nh\u01b0 u\u1ed1ng thu\u1ed1c\u2014\u0111\u00f4i khi v\u1ecb \u0111\u1eafng trong ng\u1eafn h\u1ea1n, nh\u01b0ng t\u1ed1t cho s\u1ee9c kh\u1ecfe danh m\u1ee5c \u0111\u1ea7u t\u01b0 v\u1ec1 l\u00e2u d\u00e0i!\"<\/p>  <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Novartis AG (NVS) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o cung c\u1ea5p c\u1ed5 phi\u1ebfu ni\u00eam y\u1ebft tr\u00ean NYSE v\u00e0 truy c\u1eadp qu\u1ed1c t\u1ebf<\/td><\/tr> <tr><td>2<\/td><td>Ho\u00e0n t\u1ea5t x\u00e1c minh t\u00e0i kho\u1ea3n<\/td><td>Th\u01b0\u1eddng y\u00eau c\u1ea7u gi\u1ea5y t\u1edd t\u00f9y th\u00e2n v\u00e0 b\u1eb1ng ch\u1ee9ng \u0111\u1ecba ch\u1ec9\u2014th\u01b0\u1eddng m\u1ea5t 1-2 ng\u00e0y<\/td><\/tr> <tr><td>3<\/td><td>N\u1ea1p ti\u1ec1n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i r\u1ee7i ro\u2014ngay c\u1ea3 100 USD c\u0169ng c\u00f3 th\u1ec3 b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh<\/td><\/tr> <tr><td>4<\/td><td>T\u00ecm ki\u1ebfm \"NVS\"<\/td><td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ecm \"Novartis\"<\/td><\/tr> <tr><td>5<\/td><td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td><td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o thay v\u00ec l\u1ec7nh th\u1ecb tr\u01b0\u1eddng<\/td><\/tr> <tr><td>6<\/td><td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td><td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng\u2014n\u00ean d\u01b0\u1edbi 1% gi\u00e1 tr\u1ecb giao d\u1ecbch<\/td><\/tr> <tr><td>7<\/td><td>Gi\u00e1m s\u00e1t v\u1ecb th\u1ebf<\/td><td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1 v\u00e0 theo d\u00f5i tin t\u1ee9c c\u00f4ng ty th\u01b0\u1eddng xuy\u00ean<\/td><\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0, Pocket Option cung c\u1ea5p s\u1ef1 ti\u1ebfp c\u1eadn tuy\u1ec7t v\u1eddi:<\/p> <ul> <li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u: 5 USD<\/strong>\u2014ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro th\u1ea5p<\/li> <li><strong>X\u00e1c minh nhanh<\/strong>: Quy tr\u00ecnh KYC m\u1ed9t t\u00e0i li\u1ec7u ho\u00e0n th\u00e0nh trong v\u00e0i ph\u00fat<\/li> <li><strong>Truy c\u1eadp to\u00e0n c\u1ea7u<\/strong>: Giao d\u1ecbch c\u1ed5 phi\u1ebfu M\u1ef9 t\u1eeb b\u1ea5t c\u1ee9 \u0111\u00e2u tr\u00ean th\u1ebf gi\u1edbi<\/li> <li><strong>T\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c<\/strong>: T\u00e0i li\u1ec7u h\u1ecdc t\u1eadp to\u00e0n di\u1ec7n tr\u00ean <a href=\"\/blog\">blog Pocket Option<\/a><\/li> <\/ul> <p>Giao di\u1ec7n th\u00e2n thi\u1ec7n c\u1ee7a n\u1ec1n t\u1ea3ng gi\u00fap vi\u1ec7c tham gia th\u1ecb tr\u01b0\u1eddng ch\u1ee9ng kho\u00e1n b\u1edbt \u0111\u00e1ng s\u1ee3 v\u1edbi ng\u01b0\u1eddi m\u1edbi trong khi cung c\u1ea5p c\u00f4ng c\u1ee5 chuy\u00ean nghi\u1ec7p cho nh\u00e0 \u0111\u1ea7u t\u01b0 nghi\u00eam t\u00fac.<\/p>  <h2>\ud83c\udf0d Novartis N\u0103m 2025: Nh\u00e0 L\u00e3nh \u0110\u1ea1o \u0110\u1ed5i M\u1edbi Ch\u0103m S\u00f3c S\u1ee9c Kh\u1ecfe<\/h2> <p>Novartis th\u1ed1ng l\u0129nh nh\u01b0 m\u1ed9t c\u00f4ng ty chuy\u00ean v\u1ec1 thu\u1ed1c \u0111\u1ed5i m\u1edbi, \u0111\u00e3 chuy\u1ec3n m\u00ecnh t\u1eeb t\u1eadp \u0111o\u00e0n d\u01b0\u1ee3c ph\u1ea9m \u0111a d\u1ea1ng th\u00e0nh m\u1ed9t c\u01b0\u1eddng qu\u1ed1c \u0111\u1ed5i m\u1edbi t\u1eadp trung. C\u00f4ng ty \u0111\u00e3 ti\u1ebfp c\u1eadn 296 tri\u1ec7u b\u1ec7nh nh\u00e2n tr\u00ean to\u00e0n c\u1ea7u v\u00e0o n\u0103m 2025 trong khi duy tr\u00ec t\u1eadp trung kh\u00f4ng ng\u1eebng v\u00e0o b\u1ed1n l\u0129nh v\u1ef1c \u0111i\u1ec1u tr\u1ecb c\u1ed1t l\u00f5i: b\u1ec7nh tim m\u1ea1ch-th\u1eadn-chuy\u1ec3n h\u00f3a, mi\u1ec5n d\u1ecbch h\u1ecdc, khoa th\u1ea7n kinh v\u00e0 ung th\u01b0 h\u1ecdc.<\/p> <p><strong>S\u1ef1 ki\u1ec7n th\u00fa v\u1ecb n\u0103m 2025<\/strong>: Novartis ho\u00e0n t\u1ea5t vi\u1ec7c t\u00e1ch m\u1ea3ng thu\u1ed1c generic Sandoz v\u00e0o cu\u1ed1i n\u0103m 2023, t\u1ea1o ra m\u1ed9t c\u00f4ng ty tinh g\u1ecdn, t\u1eadp trung h\u01a1n \u0111ang \u0111\u1ed5 h\u00e0ng t\u1ef7 \u0111\u00f4 la v\u00e0o nghi\u00ean c\u1ee9u li\u1ec7u ph\u00e1p gen v\u00e0 \u0111i\u1ec1u tr\u1ecb ph\u00f3ng x\u1ea1 ti\u00ean ti\u1ebfn. Tr\u1ee5 s\u1edf ch\u00ednh t\u1ea1i Basel \u0111\u00e3 tr\u1edf th\u00e0nh trung t\u00e2m \u0111\u1ed5i m\u1edbi y h\u1ecdc to\u00e0n c\u1ea7u, th\u1ef1c s\u1ef1 thay \u0111\u1ed5i c\u00e1ch ch\u00fang ta \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh nghi\u00eam tr\u1ecdng.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Ph\u00e2n T\u00edch C\u1ed5 Phi\u1ebfu Novartis: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 V\u1ecb Th\u1ebf Th\u1ecb Tr\u01b0\u1eddng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 24 th\u00e1ng 8 n\u0103m 2025, Novartis AG (NVS) giao d\u1ecbch \u1edf m\u1ee9c <strong>126,98 USD<\/strong>\u2014m\u1ed9t v\u1ecb th\u1ebf m\u1ea1nh ph\u1ea3n \u00e1nh hi\u1ec7u su\u1ea5t v\u1eefng ch\u1eafc c\u1ee7a c\u00f4ng ty v\u00e0 s\u1ef1 tin t\u01b0\u1edfng c\u1ee7a th\u1ecb tr\u01b0\u1eddng. T\u1eadp \u0111o\u00e0n d\u01b0\u1ee3c ph\u1ea9m Th\u1ee5y S\u0129 n\u00e0y kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t c\u1ed5 phi\u1ebfu th\u00f4ng th\u01b0\u1eddng; n\u00f3 l\u00e0 n\u1ec1n t\u1ea3ng c\u1ee7a s\u1ef1 \u0111\u1ed5i m\u1edbi trong ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe to\u00e0n c\u1ea7u.<\/p>\n<p><strong>\u0110\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: Ng\u00e0y 4 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y quan tr\u1ecdng ti\u1ebfp theo. \u0110\u00f3 l\u00e0 khi Novartis c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3, v\u00e0 theo l\u1ecbch s\u1eed, nh\u1eefng th\u00f4ng b\u00e1o n\u00e0y t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3. B\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn g\u1ea7n nh\u1ea5t c\u1ee7a c\u00f4ng ty v\u00e0o ng\u00e0y 17 th\u00e1ng 7 n\u0103m 2025 cho th\u1ea5y k\u1ebft qu\u1ea3 \u1ea5n t\u01b0\u1ee3ng v\u1edbi t\u0103ng tr\u01b0\u1edfng doanh s\u1ed1 hai ch\u1eef s\u1ed1 v\u00e0 m\u1edf r\u1ed9ng bi\u00ean l\u1ee3i nhu\u1eadn c\u1ed1t l\u00f5i.<\/p>\n<h3>C\u00e1ch B\u00e1o C\u00e1o L\u1ee3i Nhu\u1eadn \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu NVS<\/h3>\n<table>\n<thead>\n<tr>\n<th>Ng\u00e0y<\/th>\n<th>S\u1ef1 ki\u1ec7n<\/th>\n<th>T\u00e1c \u0111\u1ed9ng Gi\u00e1<\/th>\n<th>Th\u1eddi gian<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>17 th\u00e1ng 7, 2025<\/td>\n<td>L\u1ee3i Nhu\u1eadn Qu\u00fd 2 V\u01b0\u1ee3t K\u1ef3 V\u1ecdng<\/td>\n<td>+3,2%<\/td>\n<td>2 ng\u00e0y<\/td>\n<\/tr>\n<tr>\n<td>22 th\u00e1ng 4, 2025<\/td>\n<td>K\u1ebft Qu\u1ea3 Qu\u00fd 1<\/td>\n<td>+2,1%<\/td>\n<td>1 tu\u1ea7n<\/td>\n<\/tr>\n<tr>\n<td>5 th\u00e1ng 2, 2025<\/td>\n<td>B\u00e1o C\u00e1o H\u00e0ng N\u0103m<\/td>\n<td>+4,8%<\/td>\n<td>3 ng\u00e0y<\/td>\n<\/tr>\n<tr>\n<td>29 th\u00e1ng 10, 2024<\/td>\n<td>L\u1ee3i Nhu\u1eadn Qu\u00fd 3<\/td>\n<td>-1,5%<\/td>\n<td>Gi\u1ea3m nh\u1eb9<\/td>\n<\/tr>\n<tr>\n<td>18 th\u00e1ng 7, 2024<\/td>\n<td>K\u1ebft Qu\u1ea3 Qu\u00fd 2<\/td>\n<td>+3,6%<\/td>\n<td>T\u0103ng tr\u01b0\u1edfng b\u1ec1n v\u1eefng<\/td>\n<\/tr>\n<tr>\n<td>23 th\u00e1ng 4, 2024<\/td>\n<td>Hi\u1ec7u Su\u1ea5t Qu\u00fd 1<\/td>\n<td>+2,3%<\/td>\n<td>T\u0103ng \u0111\u1ec1u<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>M\u1eabu h\u00ecnh cho th\u1ea5y Novartis th\u01b0\u1eddng tr\u1ea3i qua \u0111\u00e0 t\u0103ng t\u00edch c\u1ef1c sau c\u00e1c b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn m\u1ea1nh, v\u1edbi nh\u1eefng \u0111i\u1ec1u ch\u1ec9nh nh\u1ecf th\u1ec9nh tho\u1ea3ng t\u1ea1o c\u01a1 h\u1ed9i mua v\u00e0o.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: Th\u00e1ng 1 &#8211; Th\u00e1ng 8 N\u0103m 2025<\/h2>\n<p>C\u1ed5 phi\u1ebfu Novartis \u0111\u00e3 th\u1ec3 hi\u1ec7n s\u1ef1 ki\u00ean c\u01b0\u1eddng v\u00e0 t\u0103ng tr\u01b0\u1edfng \u0111\u00e1ng k\u1ec3 trong s\u00e1u th\u00e1ng qua:<\/p>\n<ul>\n<li><strong>Th\u00e1ng 1 n\u0103m 2025<\/strong>: B\u1eaft \u0111\u1ea7u quanh m\u1ee9c 96,91 USD, t\u0103ng +7,61% khi nh\u00e0 \u0111\u1ea7u t\u01b0 nh\u1eadn ra l\u1ee3i \u00edch t\u1eeb t\u00e1i c\u1ea5u tr\u00fac c\u00f4ng ty<\/li>\n<li><strong>Th\u00e1ng 2 n\u0103m 2025<\/strong>: \u0110\u00e0 t\u0103ng ti\u1ebfp t\u1ee5c v\u1edbi +4,13%, \u0111\u1ea1t \u0111\u1ec9nh 113 USD nh\u1edd tin t\u1ee9c t\u00edch c\u1ef1c v\u1ec1 danh m\u1ee5c s\u1ea3n ph\u1ea9m<\/li>\n<li><strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: T\u0103ng \u1ed5n \u0111\u1ecbnh +2,23% khi th\u1ecb tr\u01b0\u1eddng ti\u1ebfp nh\u1eadn k\u1ef3 v\u1ecdng qu\u00fd 1<\/li>\n<li><strong>Th\u00e1ng 4 n\u0103m 2025<\/strong>: Giai \u0111o\u1ea1n bi\u1ebfn \u0111\u1ed9ng (+1,80%) v\u1edbi dao \u0111\u1ed9ng r\u1ed9ng t\u1eeb 97,72 \u0111\u1ebfn 114,70 USD<\/li>\n<li><strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: T\u0103ng tr\u01b0\u1edfng v\u1eefng ch\u1eafc +2,00% gi\u1eefa k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng t\u00edch c\u1ef1c<\/li>\n<li><strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: Ph\u1ee5c h\u1ed3i m\u1ea1nh +4,54% khi tin t\u1ee9c mua l\u1ea1i n\u00e2ng cao ni\u1ec1m tin<\/li>\n<li><strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: \u0110i\u1ec1u ch\u1ec9nh nh\u1eb9 -3,62% do ch\u1ed1t l\u1eddi sau \u0111\u1ee3t t\u0103ng m\u1ea1nh<\/li>\n<li><strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: Ph\u1ee5c h\u1ed3i l\u00ean m\u1ee9c hi\u1ec7n t\u1ea1i 126,98 USD, th\u1ec3 hi\u1ec7n s\u1ef1 tin t\u01b0\u1edfng c\u1ee7a nh\u00e0 \u0111\u1ea7u t\u01b0<\/li>\n<\/ul>\n<p><strong>T\u1ed5ng l\u1ee3i nhu\u1eadn 6 th\u00e1ng: Kho\u1ea3ng 28%<\/strong>\u2014v\u01b0\u1ee3t tr\u1ed9i so v\u1edbi nhi\u1ec1u \u0111\u1ed1i th\u1ee7 trong ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m v\u00e0 ch\u1ee9ng minh t\u1ea1i sao NVS v\u1eabn l\u00e0 l\u1ef1a ch\u1ecdn y\u00eau th\u00edch c\u1ee7a c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 t\u0103ng tr\u01b0\u1edfng.<\/p>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p>D\u1ef1a tr\u00ean d\u1ef1 b\u00e1o c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch hi\u1ec7n t\u1ea1i v\u00e0 hi\u1ec7u su\u1ea5t c\u00f4ng ty, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec b\u1ea1n c\u00f3 th\u1ec3 mong \u0111\u1ee3i:<\/p>\n<ul>\n<li><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: 129-135 USD (qu\u00fd l\u1ec5 m\u1ea1nh v\u00e0 ph\u00e1t tri\u1ec3n danh m\u1ee5c s\u1ea3n ph\u1ea9m) \u2192 <strong>MUA<\/strong><\/li>\n<li><strong>M\u1ee5c ti\u00eau 2026<\/strong>: 140-150 USD (t\u00edch h\u1ee3p th\u00e0nh c\u00f4ng c\u00e1c th\u01b0\u01a1ng v\u1ee5 mua l\u1ea1i g\u1ea7n \u0111\u00e2y)<\/li>\n<li><strong>D\u1ef1 b\u00e1o 2028<\/strong>: 160-180 USD (th\u1ed1ng l\u0129nh trong li\u1ec7u ph\u00e1p gen v\u00e0 mi\u1ec5n d\u1ecbch h\u1ecdc)<\/li>\n<li><strong>T\u1ea7m nh\u00ecn 2030<\/strong>: Tr\u00ean 200 USD (m\u1edf r\u1ed9ng ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe to\u00e0n c\u1ea7u v\u00e0 xu h\u01b0\u1edbng d\u00e2n s\u1ed1 gi\u00e0 h\u00f3a)<\/li>\n<\/ul>\n<p>\u0110a s\u1ed1 c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u1eabn gi\u1eef quan \u0111i\u1ec3m t\u00edch c\u1ef1c m\u1eb7c d\u00f9 c\u00f3 nh\u1eefng lo ng\u1ea1i v\u1ec1 b\u1eb1ng s\u00e1ng ch\u1ebf trong ng\u1eafn h\u1ea1n. Chi\u1ebfn l\u01b0\u1ee3c t\u1eadp trung v\u00e0o thu\u1ed1c \u0111\u1ed5i m\u1edbi v\u00e0 c\u00e1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng th\u00e0nh c\u00f4ng g\u1ea7n \u0111\u00e2y gi\u00fap Novartis c\u00f3 v\u1ecb th\u1ebf t\u0103ng tr\u01b0\u1edfng b\u1ec1n v\u1eefng d\u00e0i h\u1ea1n.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i Ro C\u1ea7n L\u01b0u \u00dd<\/h3>\n<ul>\n<li><strong>H\u1ebft h\u1ea1n b\u1eb1ng s\u00e1ng ch\u1ebf<\/strong>: Entresto, thu\u1ed1c mang l\u1ea1i 2,36 t\u1ef7 USD doanh thu qu\u00fd, s\u1eafp \u0111\u1ed1i m\u1eb7t v\u1edbi c\u1ea1nh tranh thu\u1ed1c generic (<a href=\"https:\/\/www.ainvest.com\/news\/novartis-growth-slow-patent-expirations-loom-2507\/\">B\u00e1o c\u00e1o AInvest<\/a>)<\/li>\n<li><strong>\u00c1p l\u1ef1c qu\u1ea3n l\u00fd<\/strong>: FDA t\u0103ng c\u01b0\u1eddng gi\u00e1m s\u00e1t v\u1edbi 907 th\u01b0 c\u1ea3nh b\u00e1o n\u0103m 2023 (+12% so v\u1edbi 2022)<\/li>\n<li><strong>C\u1ea3i c\u00e1ch gi\u00e1 thu\u1ed1c<\/strong>: C\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng 15-20% doanh thu t\u1eeb \u0111\u1ec1 xu\u1ea5t gi\u00e1 thu\u1ed1c c\u1ee7a ch\u00ednh ph\u1ee7 M\u1ef9<\/li>\n<li><strong>M\u1ee9c n\u1ee3<\/strong>: T\u1ef7 l\u1ec7 n\u1ee3 tr\u00ean v\u1ed1n ch\u1ee7 s\u1edf h\u1eefu 0,53 c\u1ea7n \u0111\u01b0\u1ee3c theo d\u00f5i ch\u1eb7t ch\u1ebd<\/li>\n<\/ul>\n<h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h3>\n<ul>\n<li><strong>Danh m\u1ee5c s\u1ea3n ph\u1ea9m m\u1ea1nh<\/strong>: K\u1ebft qu\u1ea3 giai \u0111o\u1ea1n 3 t\u00edch c\u1ef1c cho ianalumab trong b\u1ec7nh Sj\u00f6gren v\u00e0 ITP<\/li>\n<li><strong>Th\u01b0\u01a1ng v\u1ee5 chi\u1ebfn l\u01b0\u1ee3c<\/strong>: Ho\u00e0n t\u1ea5t th\u01b0\u01a1ng v\u1ee5 1,7 t\u1ef7 USD mua Regulus Therapeutics, t\u0103ng c\u01b0\u1eddng n\u0103ng l\u1ef1c microRNA<\/li>\n<li><strong>L\u00e3nh \u0111\u1ea1o th\u1ecb tr\u01b0\u1eddng<\/strong>: X\u1ebfp h\u1ea1ng #5 v\u1ec1 doanh s\u1ed1 d\u01b0\u1ee3c ph\u1ea9m to\u00e0n c\u1ea7u v\u1edbi \u0111\u1ea7u t\u01b0 R&#038;D kh\u1ed5ng l\u1ed3<\/li>\n<li><strong>\u1ed4n \u0111\u1ecbnh c\u1ed5 t\u1ee9c<\/strong>: L\u1ee3i su\u1ea5t 3,53% cung c\u1ea5p thu nh\u1eadp trong bi\u1ebfn \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: M\u1edf v\u1ecb th\u1ebf kh\u00f4ng qu\u00e1 5% danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n<\/li>\n<li><strong>Trung b\u00ecnh gi\u00e1<\/strong>: \u0110\u1ea7u t\u01b0 s\u1ed1 ti\u1ec1n c\u1ed1 \u0111\u1ecbnh \u0111\u1ec1u \u0111\u1eb7n thay v\u00ec c\u1ed1 g\u1eafng b\u1eaft th\u1eddi \u0111i\u1ec3m th\u1ecb tr\u01b0\u1eddng<\/li>\n<li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/strong>: Theo d\u00f5i b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn ng\u00e0y 4 th\u00e1ng 11 \u0111\u1ec3 t\u00ecm \u0111i\u1ec3m v\u00e0o ti\u1ec1m n\u0103ng<\/li>\n<li><strong>Suy ngh\u0129 d\u00e0i h\u1ea1n<\/strong>: C\u1ed5 phi\u1ebfu d\u01b0\u1ee3c ph\u1ea9m \u0111\u00f2i h\u1ecfi ki\u00ean nh\u1eabn\u2014kh\u00f4ng ph\u1ea3i c\u01a1 h\u1ed9i l\u01b0\u1edbt s\u00f3ng nhanh<\/li>\n<\/ol>\n<p>Ch\u00e2m bi\u1ebfm: &#8220;Giao d\u1ecbch NVS gi\u1ed1ng nh\u01b0 u\u1ed1ng thu\u1ed1c\u2014\u0111\u00f4i khi v\u1ecb \u0111\u1eafng trong ng\u1eafn h\u1ea1n, nh\u01b0ng t\u1ed1t cho s\u1ee9c kh\u1ecfe danh m\u1ee5c \u0111\u1ea7u t\u01b0 v\u1ec1 l\u00e2u d\u00e0i!&#8221;<\/p>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Novartis AG (NVS) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o cung c\u1ea5p c\u1ed5 phi\u1ebfu ni\u00eam y\u1ebft tr\u00ean NYSE v\u00e0 truy c\u1eadp qu\u1ed1c t\u1ebf<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n t\u1ea5t x\u00e1c minh t\u00e0i kho\u1ea3n<\/td>\n<td>Th\u01b0\u1eddng y\u00eau c\u1ea7u gi\u1ea5y t\u1edd t\u00f9y th\u00e2n v\u00e0 b\u1eb1ng ch\u1ee9ng \u0111\u1ecba ch\u1ec9\u2014th\u01b0\u1eddng m\u1ea5t 1-2 ng\u00e0y<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>N\u1ea1p ti\u1ec1n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i r\u1ee7i ro\u2014ngay c\u1ea3 100 USD c\u0169ng c\u00f3 th\u1ec3 b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>T\u00ecm ki\u1ebfm &#8220;NVS&#8221;<\/td>\n<td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ecm &#8220;Novartis&#8221;<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td>\n<td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o thay v\u00ec l\u1ec7nh th\u1ecb tr\u01b0\u1eddng<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td>\n<td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng\u2014n\u00ean d\u01b0\u1edbi 1% gi\u00e1 tr\u1ecb giao d\u1ecbch<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Gi\u00e1m s\u00e1t v\u1ecb th\u1ebf<\/td>\n<td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1 v\u00e0 theo d\u00f5i tin t\u1ee9c c\u00f4ng ty th\u01b0\u1eddng xuy\u00ean<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0, Pocket Option cung c\u1ea5p s\u1ef1 ti\u1ebfp c\u1eadn tuy\u1ec7t v\u1eddi:<\/p>\n<ul>\n<li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u: 5 USD<\/strong>\u2014ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro th\u1ea5p<\/li>\n<li><strong>X\u00e1c minh nhanh<\/strong>: Quy tr\u00ecnh KYC m\u1ed9t t\u00e0i li\u1ec7u ho\u00e0n th\u00e0nh trong v\u00e0i ph\u00fat<\/li>\n<li><strong>Truy c\u1eadp to\u00e0n c\u1ea7u<\/strong>: Giao d\u1ecbch c\u1ed5 phi\u1ebfu M\u1ef9 t\u1eeb b\u1ea5t c\u1ee9 \u0111\u00e2u tr\u00ean th\u1ebf gi\u1edbi<\/li>\n<li><strong>T\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c<\/strong>: T\u00e0i li\u1ec7u h\u1ecdc t\u1eadp to\u00e0n di\u1ec7n tr\u00ean <a href=\"\/blog\">blog Pocket Option<\/a><\/li>\n<\/ul>\n<p>Giao di\u1ec7n th\u00e2n thi\u1ec7n c\u1ee7a n\u1ec1n t\u1ea3ng gi\u00fap vi\u1ec7c tham gia th\u1ecb tr\u01b0\u1eddng ch\u1ee9ng kho\u00e1n b\u1edbt \u0111\u00e1ng s\u1ee3 v\u1edbi ng\u01b0\u1eddi m\u1edbi trong khi cung c\u1ea5p c\u00f4ng c\u1ee5 chuy\u00ean nghi\u1ec7p cho nh\u00e0 \u0111\u1ea7u t\u01b0 nghi\u00eam t\u00fac.<\/p>\n<h2>\ud83c\udf0d Novartis N\u0103m 2025: Nh\u00e0 L\u00e3nh \u0110\u1ea1o \u0110\u1ed5i M\u1edbi Ch\u0103m S\u00f3c S\u1ee9c Kh\u1ecfe<\/h2>\n<p>Novartis th\u1ed1ng l\u0129nh nh\u01b0 m\u1ed9t c\u00f4ng ty chuy\u00ean v\u1ec1 thu\u1ed1c \u0111\u1ed5i m\u1edbi, \u0111\u00e3 chuy\u1ec3n m\u00ecnh t\u1eeb t\u1eadp \u0111o\u00e0n d\u01b0\u1ee3c ph\u1ea9m \u0111a d\u1ea1ng th\u00e0nh m\u1ed9t c\u01b0\u1eddng qu\u1ed1c \u0111\u1ed5i m\u1edbi t\u1eadp trung. C\u00f4ng ty \u0111\u00e3 ti\u1ebfp c\u1eadn 296 tri\u1ec7u b\u1ec7nh nh\u00e2n tr\u00ean to\u00e0n c\u1ea7u v\u00e0o n\u0103m 2025 trong khi duy tr\u00ec t\u1eadp trung kh\u00f4ng ng\u1eebng v\u00e0o b\u1ed1n l\u0129nh v\u1ef1c \u0111i\u1ec1u tr\u1ecb c\u1ed1t l\u00f5i: b\u1ec7nh tim m\u1ea1ch-th\u1eadn-chuy\u1ec3n h\u00f3a, mi\u1ec5n d\u1ecbch h\u1ecdc, khoa th\u1ea7n kinh v\u00e0 ung th\u01b0 h\u1ecdc.<\/p>\n<p><strong>S\u1ef1 ki\u1ec7n th\u00fa v\u1ecb n\u0103m 2025<\/strong>: Novartis ho\u00e0n t\u1ea5t vi\u1ec7c t\u00e1ch m\u1ea3ng thu\u1ed1c generic Sandoz v\u00e0o cu\u1ed1i n\u0103m 2023, t\u1ea1o ra m\u1ed9t c\u00f4ng ty tinh g\u1ecdn, t\u1eadp trung h\u01a1n \u0111ang \u0111\u1ed5 h\u00e0ng t\u1ef7 \u0111\u00f4 la v\u00e0o nghi\u00ean c\u1ee9u li\u1ec7u ph\u00e1p gen v\u00e0 \u0111i\u1ec1u tr\u1ecb ph\u00f3ng x\u1ea1 ti\u00ean ti\u1ebfn. Tr\u1ee5 s\u1edf ch\u00ednh t\u1ea1i Basel \u0111\u00e3 tr\u1edf th\u00e0nh trung t\u00e2m \u0111\u1ed5i m\u1edbi y h\u1ecdc to\u00e0n c\u1ea7u, th\u1ef1c s\u1ef1 thay \u0111\u1ed5i c\u00e1ch ch\u00fang ta \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh nghi\u00eam tr\u1ecdng.<\/p>\n"},"faq":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 b\u1eaft \u0111\u1ea7u mua c\u1ed5 phi\u1ebfu Novartis AG (NVS)?","answer":"B\u1ea1n c\u1ea7n ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch h\u1ed7 tr\u1ee3 c\u1ed5 phi\u1ebfu ni\u00eam y\u1ebft tr\u00ean NYSE, ho\u00e0n t\u1ea5t x\u00e1c minh t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 c\u1ed5 phi\u1ebfu \"NVS\", ch\u1ecdn lo\u1ea1i l\u1ec7nh ph\u00f9 h\u1ee3p, x\u00e1c nh\u1eadn giao d\u1ecbch v\u00e0 theo d\u00f5i v\u1ecb th\u1ebf c\u1ee7a b\u1ea1n."},{"question":"Novartis AG c\u00f3 nh\u1eefng r\u1ee7i ro n\u00e0o c\u1ea7n l\u01b0u \u00fd?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m h\u1ebft h\u1ea1n b\u1eb1ng s\u00e1ng ch\u1ebf thu\u1ed1c ch\u1ee7 l\u1ef1c Entresto, \u00e1p l\u1ef1c t\u1eeb c\u01a1 quan qu\u1ea3n l\u00fd FDA, c\u00e1c \u0111\u1ec1 xu\u1ea5t c\u1ea3i c\u00e1ch gi\u00e1 thu\u1ed1c t\u1ea1i M\u1ef9 v\u00e0 m\u1ee9c n\u1ee3 c\u1ea7n \u0111\u01b0\u1ee3c ki\u1ec3m so\u00e1t ch\u1eb7t ch\u1ebd."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a c\u1ed5 phi\u1ebfu Novartis trong giai \u0111o\u1ea1n 2025-2030 ra sao?","answer":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu s\u1ebd t\u0103ng t\u1eeb kho\u1ea3ng 129-135 USD v\u00e0o cu\u1ed1i n\u0103m 2025 l\u00ean tr\u00ean 200 USD v\u00e0o n\u0103m 2030 nh\u1edd v\u00e0o c\u00e1c ph\u00e1t tri\u1ec3n trong li\u1ec7u ph\u00e1p gen, mi\u1ec5n d\u1ecbch h\u1ecdc v\u00e0 m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe to\u00e0n c\u1ea7u."},{"question":"Nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi n\u00ean l\u00e0m g\u00ec khi \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Novartis?","answer":"N\u00ean b\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n nh\u1ecf, \u00e1p d\u1ee5ng chi\u1ebfn l\u01b0\u1ee3c trung b\u00ecnh gi\u00e1, \u0111\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1 quanh c\u00e1c b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn quan tr\u1ecdng v\u00e0 ki\u00ean nh\u1eabn \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n."},{"question":"T\u1ea1i sao n\u00ean ch\u1ecdn Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 c\u1ed5 phi\u1ebfu Novartis?","answer":"Pocket Option c\u00f3 s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, quy tr\u00ecnh x\u00e1c minh nhanh, truy c\u1eadp to\u00e0n c\u1ea7u v\u00e0 cung c\u1ea5p t\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c phong ph\u00fa, ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi b\u1eaft \u0111\u1ea7u."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 b\u1eaft \u0111\u1ea7u mua c\u1ed5 phi\u1ebfu Novartis AG (NVS)?","answer":"B\u1ea1n c\u1ea7n ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch h\u1ed7 tr\u1ee3 c\u1ed5 phi\u1ebfu ni\u00eam y\u1ebft tr\u00ean NYSE, ho\u00e0n t\u1ea5t x\u00e1c minh t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 c\u1ed5 phi\u1ebfu \"NVS\", ch\u1ecdn lo\u1ea1i l\u1ec7nh ph\u00f9 h\u1ee3p, x\u00e1c nh\u1eadn giao d\u1ecbch v\u00e0 theo d\u00f5i v\u1ecb th\u1ebf c\u1ee7a b\u1ea1n."},{"question":"Novartis AG c\u00f3 nh\u1eefng r\u1ee7i ro n\u00e0o c\u1ea7n l\u01b0u \u00fd?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m h\u1ebft h\u1ea1n b\u1eb1ng s\u00e1ng ch\u1ebf thu\u1ed1c ch\u1ee7 l\u1ef1c Entresto, \u00e1p l\u1ef1c t\u1eeb c\u01a1 quan qu\u1ea3n l\u00fd FDA, c\u00e1c \u0111\u1ec1 xu\u1ea5t c\u1ea3i c\u00e1ch gi\u00e1 thu\u1ed1c t\u1ea1i M\u1ef9 v\u00e0 m\u1ee9c n\u1ee3 c\u1ea7n \u0111\u01b0\u1ee3c ki\u1ec3m so\u00e1t ch\u1eb7t ch\u1ebd."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a c\u1ed5 phi\u1ebfu Novartis trong giai \u0111o\u1ea1n 2025-2030 ra sao?","answer":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu s\u1ebd t\u0103ng t\u1eeb kho\u1ea3ng 129-135 USD v\u00e0o cu\u1ed1i n\u0103m 2025 l\u00ean tr\u00ean 200 USD v\u00e0o n\u0103m 2030 nh\u1edd v\u00e0o c\u00e1c ph\u00e1t tri\u1ec3n trong li\u1ec7u ph\u00e1p gen, mi\u1ec5n d\u1ecbch h\u1ecdc v\u00e0 m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe to\u00e0n c\u1ea7u."},{"question":"Nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi n\u00ean l\u00e0m g\u00ec khi \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Novartis?","answer":"N\u00ean b\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n nh\u1ecf, \u00e1p d\u1ee5ng chi\u1ebfn l\u01b0\u1ee3c trung b\u00ecnh gi\u00e1, \u0111\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1 quanh c\u00e1c b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn quan tr\u1ecdng v\u00e0 ki\u00ean nh\u1eabn \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n."},{"question":"T\u1ea1i sao n\u00ean ch\u1ecdn Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 c\u1ed5 phi\u1ebfu Novartis?","answer":"Pocket Option c\u00f3 s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, quy tr\u00ecnh x\u00e1c minh nhanh, truy c\u1eadp to\u00e0n c\u1ea7u v\u00e0 cung c\u1ea5p t\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c phong ph\u00fa, ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi b\u1eaft \u0111\u1ea7u."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Novartis AG (NVS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Novartis AG (NVS)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Novartis AG (NVS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Novartis AG (NVS)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-24T13:48:43+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Novartis AG (NVS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Novartis AG (NVS)\",\"datePublished\":\"2025-08-24T13:48:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Novartis AG (NVS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Novartis AG (NVS)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"datePublished\":\"2025-08-24T13:48:43+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Novartis AG (NVS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Novartis AG (NVS)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Novartis AG (NVS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Novartis AG (NVS)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Novartis AG (NVS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Novartis AG (NVS)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-24T13:48:43+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Novartis AG (NVS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Novartis AG (NVS)","datePublished":"2025-08-24T13:48:43+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Novartis AG (NVS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Novartis AG (NVS)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","datePublished":"2025-08-24T13:48:43+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Novartis AG (NVS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Novartis AG (NVS)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":344690,"slug":"how-to-buy-novartis-ag","post_title":"Como comprar a\u00e7\u00f5es da Novartis AG (NVS) - Investimento em a\u00e7\u00f5es da Novartis AG (NVS)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-novartis-ag\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/344694","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=344694"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/344694\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334027"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=344694"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=344694"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=344694"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}